EP2545905A1 — A new therapeutical composition containing apomorphine as active ingredient
Assigned to Britannia Pharmaceuticals Ltd · Expires 2013-01-16 · 13y expired
What this patent protects
The present invention relates to a pharmaceutical composition containing apomorphine as the active pharmaceutical ingredient, and more particularly a pharmaceutical formulation for parenteral administration, having a co-solvent, an anti-oxidant and a pH of greater than 4.
USPTO Abstract
The present invention relates to a pharmaceutical composition containing apomorphine as the active pharmaceutical ingredient, and more particularly a pharmaceutical formulation for parenteral administration, having a co-solvent, an anti-oxidant and a pH of greater than 4.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.